FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2024
Back to search
Official data from USPTO
HISTOCYTE LABORATORIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HISTOCYTE LABORATORIES
ST13
US500000079342045Class
1, 5
Filing
79342045
Registration
7383168
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
11/23/2024
Trademark type
Word
Nice classes
1, 5
Filing date
12/08/2021
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HistoCyte Laboratories Ltd
Representatives
Mari-Elise Paul McBrayer PLLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
diagnostic chemicals other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests other than for medical or veterinary purposes; chemical reagents for use in diagnostic testsother than for medical or veterinary use; reagents for laboratory purposes other than for medical or veterinary purposes; diagnostic reagents for in-vitro use other than medical or veterinary purposes; diagnostic chemical and biological reagents used for molecular testing for clinical diagnosticsother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; reagents for scientific purposes; reagents for medical research; reagents for research purposes; diagnostic reagents for scientific or research use; diagnostic testing materialsother than for medical use; diagnostic preparations for scientific or research use
Class 5
Medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; chemical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for use in diagnostic tests for medical purposes; biological tissue cultures for medical purposes; diagnostic agents for medical use; in vitro diagnostic preparations for medical use
Publications
History of USPTO decisions and trademark events.
52 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/06/2024
FIMP
FINAL DISPOSITION PROCESSED
11/06/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/14/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
GPNX
NOTIFICATION PROCESSED BY IB
02/26/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/19/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/19/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/19/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/19/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/22/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/15/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/15/2023
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
10/02/2023
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
10/02/2023
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
10/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/11/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/23/2023
GNFR
FINAL REFUSAL E-MAILED
06/23/2023
CNFR
FINAL REFUSAL WRITTEN
06/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2023
ATRV
ATTORNEY REVIEW COMPLETED
05/11/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
05/03/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/06/2023
RFNT
REFUSAL PROCESSED BY IB
12/22/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/25/2022
RFRR
REFUSAL PROCESSED BY MPU
11/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/17/2022
CNRT
NON-FINAL ACTION WRITTEN
09/16/2022
DOCK
ASSIGNED TO EXAMINER
09/16/2022
MAFR
APPLICATION FILING RECEIPT MAILED
06/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/09/2022
Continuous trademark protection
Get notified about every new filing that threatens HISTOCYTE LABORATORIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.